Mandadi Tilak 4
4 · CVS HEALTH Corp · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
- Award
Stock Option
2024-04-01$79.56/sh+67,920$5,403,715→ 67,920 totalExercise: $79.56From: 2025-04-01Exp: 2034-04-01→ Common Stock (67,920 underlying) - Award
Common Stock (RSU)
2024-04-01+16,339→ 82,904 total
Footnotes (2)
- [F1]Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.
- [F2]Option becomes exercisable in four equal annual installments, commencing 4/1/2025.